Skip to main content
DNA Labs India

SARS-CoV-2 Antibody IgG CLIA Test

DNA Labs India | ISO 9001:2015 Certified

SARS-CoV-2 Antibody IgG CLIA Test

Short Name: COVID-19 IgG CLIA

Also known as: COVID-19 IgG Antibody Test, SARS-CoV-2 IgG Serology Test, Coronavirus Antibody IgG CLIA Test, SARS-CoV-2 IgG Immunoassay

SARS-CoV-2 Antibody IgG CLIA Test test available at DNA Labs India for ₹819. Uses Chemiluminescence Immunoassay (CLIA) on Serum samples. Results in Results are typically available within 1 week after sample collection. You will receive your report via the online portal, email, or WhatsApp.. Free home collection in 300+ cities across India.

Immunology🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of the SARS-CoV-2 Antibody IgG CLIA Test is to detect the presence of IgG antibodies against the SARS-CoV-2 virus in a blood sample. This test helps determine if an individual has been previously exposed to COVID-19 and has developed an immune response. It is not used to diagnose an active infection but rather to assess past infection status. The test is also valuable for seroprevalence studies, post-vaccination antibody monitoring, and helping researchers understand the spread and immune dynamics of COVID-19 within populations.

Test Code
40
CPT Code
86769
ICD Code
U07.1
Price
₹819
Sample Type
Serum
Result Time
Results are typically available within 1 week after sample collection. You will receive your report via the online portal, email, or WhatsApp.
Fasting Required
No
Method
Chemiluminescence Immunoassay (CLIA)
Step 1

Sample Collection

A duly filled Covid-19 Antibody Test Form (Form 45) is mandatory. No fasting is required. Inform the phlebotomist about any recent COVID-19 vaccination or known immunological conditions.

Method: Venipuncture

Step 2

Laboratory Analysis

A blood sample of 3 mL (minimum 1 mL) will be collected from a vein in your arm using standard venipuncture technique into a Serum Separator Tube (SST).

Step 3

Report Delivery

Apply pressure to the puncture site with a cotton ball or bandage to stop bleeding. The sample will be processed and shipped refrigerated or frozen to the laboratory.

Timeline: Results are typically available within 1 week after sample collection. You will receive your report via the online portal, email, or WhatsApp.

Patient Instructions

1
Before the Test:No special preparation is required. A duly filled Covid-19 Antibody Test Form (Form 45) is mandatory. No fasting is needed. Inform your healthcare provider about any recent COVID-19 vaccination.
2
During the Test:A healthcare professional will collect approximately 3 mL of blood from a vein in your arm using a needle and syringe into a Serum Separator Tube (SST). The procedure typically takes less than 5 minutes.
3
After the Test:After blood collection, a small bandage will be applied to the puncture site. You may resume normal activities immediately. Mild soreness or bruising at the site may occur and resolves on its own.

About This Test

Who Should Get This Test

The purpose of the SARS-CoV-2 Antibody IgG CLIA Test is to detect the presence of IgG antibodies against the SARS-CoV-2 virus in a blood sample. This test helps determine if an individual has been previously exposed to COVID-19 and has developed an immune response. It is not used to diagnose an active infection but rather to assess past infection status. The test is also valuable for seroprevalence studies, post-vaccination antibody monitoring, and helping researchers understand the spread and immune dynamics of COVID-19 within populations.

How to Prepare

  • Duly filled Covid-19 Antibody Test Form (Form 45) is mandatory before sample collection
  • No fasting is required for this test
  • Inform the phlebotomist about any recent COVID-19 vaccination
  • 3 mL of blood will be collected in a Serum Separator Tube (SST)
  • Sample should be shipped refrigerated or frozen to maintain stability
  • Avoid strenuous activity at the puncture site for a few hours after collection

Doctor's Notes

Reviewed by — MBBS, MD (General Medicine) · Reg. No. 8052

"As an Infectious Disease specialist, I recommend the SARS-CoV-2 IgG CLIA test for patients who suspect they may have had a past COVID-19 infection but were not tested during the acute phase. This test is valuable for understanding individual and population-level exposure to the virus. It is also useful in seroprevalence assessments and post-vaccination antibody monitoring. However, it is important to note that this test cannot diagnose active COVID-19 infection and should not replace RT-PCR or antigen testing for symptomatic individuals. A reactive IgG result suggests past infection or an immune response, but the level and duration of protection cannot be determined by this test alone. Always consult your healthcare provider for proper interpretation of results and clinical guidance."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeSerum
Sample Volume3 mL (1 mL min.)
ContainerSerum Separator Tube (SST)
Collection MethodVenipuncture

Sample Stability

Room Temperature8 hours
Refrigerated (2–8°C)48 hours
Frozen (-20°C)1 week
Sample Rejection Criteria:
  • Sample collected without a duly filled Covid-19 Antibody Test Form (Form 45)
  • Insufficient sample volume (less than 1 mL serum)
  • Hemolyzed, lipemic, or grossly contaminated sample
  • Sample stored beyond stability limits (Room Temp >8 hrs, Refrigerated >48 hrs, Frozen >1 week)
  • Leaking or improperly labeled SST tube

Understanding Your Results

The SARS-CoV-2 Antibody IgG CLIA Test measures IgG antibodies against SARS-CoV-2 in the blood. Results are reported as Reactive or Non-reactive based on the Signal to Cutoff (S/CO) ratio. Interpretation should always be done in the context of clinical history and symptoms. Below is a general guide to result interpretation:
📊

Non-reactive (<1.0 S/CO)

No detectable IgG antibodies to SARS-CoV-2 were found. This may indicate no past infection, testing too early after exposure, or an inadequate immune response. Clinical correlation is recommended.

📊

Reactive (≥1.0 S/CO)

IgG antibodies to SARS-CoV-2 were detected. This suggests a past infection or immune response to the virus or COVID-19 vaccination. A reactive result does not guarantee immunity against future infection. Consult your physician for further guidance.

⚠️ When to Consult a Doctor:

Consult your doctor if your test result is reactive and you are unsure about your immune status, if you are currently experiencing COVID-19 symptoms (this test is not for active infection diagnosis), if you are immunocompromised and your result is non-reactive despite suspected exposure, or if you need guidance on vaccination and booster doses based on your antibody levels.

Limitations

  • This test cannot diagnose an active or current COVID-19 infection
  • IgG antibody levels may wane over time and may not be detectable months after infection
  • A reactive result does not confirm immunity or protection against future SARS-CoV-2 infection
  • Cannot differentiate between antibodies produced by natural infection versus COVID-19 vaccination
  • Results should always be interpreted in conjunction with clinical history and other diagnostic findings

Risks & Considerations

  • Minor bruising or soreness at the blood draw site
  • Slight risk of infection at the puncture site
  • Rarely, lightheadedness or dizziness during or after blood collection
  • False-negative results if tested too early after infection
  • False-positive results due to cross-reactivity with other coronaviruses or recent vaccination

Interfering Factors

  • Recent COVID-19 vaccination may produce detectable IgG antibodies unrelated to natural infection
  • Immunocompromised individuals may not produce detectable IgG levels despite past infection
  • Testing too early after infection (before 1–2 weeks) may yield false-negative results due to insufficient antibody development
  • Cross-reactivity with antibodies from other common human coronaviruses
  • Hemolyzed, lipemic, or contaminated serum samples may affect test accuracy

Compare With Similar Tests

TestSARS-CoV-2 Antibody IgG CLIA TestSARS-CoV-2 RT-PCR TestCOVID-19 Rapid Antigen TestSARS-CoV-2 Antibody IgM CLIA TestSARS-CoV-2 Total Antibody Test
ComparisonSARS-CoV-2 Antibody IgG CLIA Test

Frequently Asked Questions

What is the SARS-CoV-2 Antibody IgG CLIA Test?
The SARS-CoV-2 Antibody IgG CLIA Test is a blood test that uses chemiluminescence immunoassay (CLIA) technology to detect IgG antibodies produced by the body in response to the SARS-CoV-2 virus. It helps determine if an individual has been previously infected with COVID-19.
What is the cost of the SARS-CoV-2 Antibody IgG CLIA Test at DNA Labs India?
The cost of the SARS-CoV-2 Antibody IgG CLIA Test at DNA Labs India is Rs 819.0 (INR). This price includes free home sample collection across India.
Can this test diagnose an active COVID-19 infection?
No, the SARS-CoV-2 Antibody IgG CLIA Test is not designed to diagnose active COVID-19 infections. It detects IgG antibodies, which are produced after the initial immune response. For diagnosing active infection, RT-PCR or rapid antigen tests should be used.
Who should get the SARS-CoV-2 Antibody IgG CLIA Test?
This test is recommended for individuals who suspect they had a past COVID-19 infection but were not tested during the acute phase, those with mild or asymptomatic symptoms, individuals involved in seroprevalence studies, and those wanting to assess post-infection or post-vaccination immune response.
What sample is required for this test?
A blood sample of 3 mL (minimum 1 mL) of serum collected in a Serum Separator Tube (SST) is required. The sample should be shipped refrigerated or frozen to the laboratory.
Is Form 45 mandatory for this test?
Yes, a duly filled Covid-19 Antibody Test Form (Form 45) is mandatory for the SARS-CoV-2 Antibody IgG CLIA Test. The sample will not be processed without this form.
How long does it take to get the results?
Results for the SARS-CoV-2 Antibody IgG CLIA Test are typically available within 1 week after sample collection. Reports can be accessed via the online portal, email, or WhatsApp.
What does a reactive result mean?
A reactive result (?1.0 S/CO) indicates that IgG antibodies to SARS-CoV-2 have been detected in your blood. This suggests you have been previously infected with the virus or have developed an immune response through vaccination. It does not confirm immunity against future infection.
What does a non-reactive result mean?
A non-reactive result (<1.0 S/CO) means no detectable IgG antibodies to SARS-CoV-2 were found. This could mean you have not been infected, were tested too early after exposure, or your body did not produce a measurable antibody response. Consult your doctor for further evaluation.
Is home sample collection available for this test?
Yes, DNA Labs India offers free home sample collection for the SARS-CoV-2 Antibody IgG CLIA Test across India. You can book your appointment online and a trained phlebotomist will visit your home to collect the sample.
Does a positive IgG antibody result mean I am immune to COVID-19?
A reactive IgG result indicates past infection or immune response but does not confirm complete immunity against future COVID-19 infection. The level and duration of protection may vary. Continue to follow public health guidelines and consult your physician for personalized advice.
Can recent COVID-19 vaccination affect this test result?
Yes, COVID-19 vaccination can stimulate the production of IgG antibodies, which may result in a reactive test result. This test cannot differentiate between antibodies produced by natural infection and those produced by vaccination. Inform your doctor about your vaccination history when interpreting results.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.